# Data Dictionary - Quick Start Guide

**–î–∞—Ç–∞**: 2025-10-16  
**–í–µ—Ä—Å–∏—è**: 1.0  
**–î–ª—è**: Development Team, QA Team, Management

---

## üö® CRITICAL ALERT

**DS.md –≤–µ—Ä—Å–∏—è 1.0 —É—Å—Ç–∞—Ä–µ–ª–∞ –∏ –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã–º —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º!**

```text
‚ùå FDA 21 CFR Part 11: 45% coverage (—Ç—Ä–µ–±—É–µ—Ç—Å—è 95%+)
‚ùå EU GMP Annex 11: 55% coverage (—Ç—Ä–µ–±—É–µ—Ç—Å—è 95%+)
‚ö†Ô∏è ALCOA+: 72% coverage (—Ç—Ä–µ–±—É–µ—Ç—Å—è 90%+)

üî¥ 40 –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏—Ö gaps
üü† 67 –≤—ã—Å–æ–∫–æ–ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω—ã—Ö issues
üü° 88 —Å—Ä–µ–¥–Ω–∏—Ö issues

üìÖ Timeline –¥–æ compliance: 6 –Ω–µ–¥–µ–ª—å
üí∞ –°—Ç–æ–∏–º–æ—Å—Ç—å –∏—Å–ø—Ä–∞–≤–ª–µ–Ω–∏—è: $50K-$100K
üíÄ –°—Ç–æ–∏–º–æ—Å—Ç—å –ù–ï –∏—Å–ø—Ä–∞–≤–ª–µ–Ω–∏—è: $200K-$500K + regulatory —Ä–∏—Å–∫–∏
```

---

## üìö –î–æ–∫—É–º–µ–Ω—Ç—ã –¥–ª—è –ß—Ç–µ–Ω–∏—è

### –ù–∞—á–Ω–∏—Ç–µ –∑–¥–µ—Å—å

1. **[DATA_DICTIONARY_SUMMARY.md](./DATA_DICTIONARY_SUMMARY.md)** (5 –º–∏–Ω)
   - Executive summary
   - –¢–æ–ø-5 –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–±–ª–µ–º
   - Next steps

2. **[DS_COMPLIANCE_MATRIX.md](./DS_COMPLIANCE_MATRIX.md)** (10 –º–∏–Ω)
   - –ú–∞—Ç—Ä–∏—Ü–∞ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏—è
   - Coverage statistics
   - –ß—Ç–æ –æ—Ç—Å—É—Ç—Å—Ç–≤—É–µ—Ç

3. **[DS_UPDATE_ACTION_PLAN.md](./DS_UPDATE_ACTION_PLAN.md)** (15 –º–∏–Ω)
   - –ü–æ—à–∞–≥–æ–≤—ã–π –ø–ª–∞–Ω
   - Timeline —Å milestones
   - Acceptance criteria

### –î–ª—è –¥–µ—Ç–∞–ª—å–Ω–æ–≥–æ –∏–∑—É—á–µ–Ω–∏—è

4. **[DATA_DICTIONARY_COMPLIANCE_AUDIT.md](./DATA_DICTIONARY_COMPLIANCE_AUDIT.md)** (1 —á–∞—Å)
   - –ü–æ–ª–Ω—ã–π audit report (74KB)
   - –í—Å–µ 195 findings
   - SQL –ø—Ä–∏–º–µ—Ä—ã –¥–ª—è –∫–∞–∂–¥–æ–π —Å—Ç—Ä—É–∫—Ç—É—Ä—ã

---

## üéØ –ß—Ç–æ –ù—É–∂–Ω–æ –°–¥–µ–ª–∞—Ç—å

### –≠—Ç–∞–ø 1: –ö—Ä–∏—Ç–∏—á–µ—Å–∫–∏–µ –°—Ç—Ä—É–∫—Ç—É—Ä—ã (–ù–µ–¥–µ–ª–∏ 1-2) - –ë–õ–û–ö–ï–†

#### –û—Ç—Å—É—Ç—Å—Ç–≤—É—é—â–∏–µ –º–æ–¥—É–ª–∏

- [ ] **DS-CHG-001/002/003**: Change Control System
  - Requirement: EU GMP Annex 11 Clause 12
  - Tables: change_requests, change_approvals, change_history

- [ ] **DS-DEV-001/002**: Deviation Management
  - Requirement: EU GMP Annex 11 Clause 13
  - Tables: deviations, root_cause_analyses

- [ ] **DS-CAPA-001**: CAPA System
  - Requirement: ICH Q10
  - Tables: capa_records

- [ ] **DS-VAL-001/002/003**: Validation Management
  - Requirement: FDA 21 CFR Part 11 ¬ß 11.10(a)
  - Tables: validation_protocols, test_cases, periodic_reviews

- [ ] **DS-DI-004/005**: Data Retention & Archive
  - Requirement: FDA 21 CFR Part 11 ¬ß 11.10(c)
  - Tables: retention_policies, archived_records

- [ ] **DS-WF-004/005**: Workflow Management
  - Requirement: FDA 21 CFR Part 11 ¬ß 11.10(f)
  - Tables: workflow_definitions, workflow_executions

#### –î–æ–ø–æ–ª–Ω–∏—Ç—å —Å—É—â–µ—Å—Ç–≤—É—é—â–∏–µ

- [ ] **DS-ES-001**: Electronic Signatures
  - Add: `meaning`, `signed_entity_type`, `signed_entity_id`, `linked_record_hash`
  - Requirement: FDA ¬ß 11.50 & ¬ß 11.70

- [ ] **DS-DI-002**: Audit Trail
  - Add: `review_status`, `validation_status`, `retention_category`, `archive_status`
  - Requirement: FDA ¬ß 11.10(e)

- [ ] **DS-AUTH-001**: Users
  - Add: `training_current_status`, `gxp_training_expiry`, `qualification_status`
  - Requirement: EU GMP Annex 11 Clause 2

- [ ] **DS-PR-001**: Suppliers
  - Add: `gxp_critical`, `vendor_qualification_status`, `audit_frequency`
  - Requirement: EU GMP Annex 11 Clause 7

### –≠—Ç–∞–ø 2: –í—ã—Å–æ–∫–æ–ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω—ã–µ (–ù–µ–¥–µ–ª–∏ 3-4)

- [ ] DS-DOC-001/002/003: Document Control
- [ ] DS-QE-001: Quality Events
- [ ] DS-PR-003: Vendor Audits
- [ ] Validation metadata –¥–ª—è –≤—Å–µ—Ö GxP-critical tables

### –≠—Ç–∞–ø 3: –†–µ—Å—Ç—Ä—É–∫—Ç—É—Ä–∏–∑–∞—Ü–∏—è (–ù–µ–¥–µ–ª–∏ 5-6)

- [ ] –°–æ–∑–¥–∞—Ç—å `_definitions/` —Å—Ç—Ä—É–∫—Ç—É—Ä—É (SSOT)
- [ ] –°–æ–∑–¥–∞—Ç—å `views/` –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∏—è
- [ ] –£—Å—Ç—Ä–∞–Ω–∏—Ç—å –¥—É–±–ª–∏—Ä–æ–≤–∞–Ω–∏–µ
- [ ] –§–∏–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞—Ç—å compliance mapping

---

## üîë –ö–ª—é—á–µ–≤—ã–µ –ö–æ–Ω—Ü–µ–ø—Ü–∏–∏

### ALCOA+ –ü—Ä–∏–Ω—Ü–∏–ø—ã

–ö–∞–∂–¥–∞—è —Ç–∞–±–ª–∏—Ü–∞ –¥–æ–ª–∂–Ω–∞ –æ–±–µ—Å–ø–µ—á–∏–≤–∞—Ç—å:

- **A**ttributable: `performed_by`, `created_by` –ø–æ–ª—è
- **L**egible: UTF-8, —Å—Ç—Ä—É–∫—Ç—É—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ
- **C**ontemporaneous: `timestamp` —Å DEFAULT now()
- **O**riginal: Immutable storage (ImmuDB)
- **A**ccurate: Zod validation, FK constraints
- **C**omplete: NOT NULL –¥–ª—è –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –ø–æ–ª–µ–π
- **C**onsistent: Uniform schema
- **E**nduring: Retention policies
- **A**vailable: Indexed, –¥–æ—Å—Ç—É–ø–Ω–æ –¥–ª—è audit

### Validation Lifecycle

–í—Å–µ GxP-critical tables –¥–æ–ª–∂–Ω—ã –∏–º–µ—Ç—å:

```sql
validation_status       VARCHAR(20),
validation_protocol_id  UUID,
last_validated_at       TIMESTAMP,
next_review_date        DATE
```

### Electronic Signatures (FDA ¬ß 11.50 & ¬ß 11.70)

–ü–æ–¥–ø–∏—Å–∏ –¥–æ–ª–∂–Ω—ã —Å–æ–¥–µ—Ä–∂–∞—Ç—å:

- **Meaning**: "review", "approval", "verification"
- **Linking**: –ù–µ—Ä–∞–∑—Ä—ã–≤–Ω–∞—è —Å–≤—è–∑—å —Å –ø–æ–¥–ø–∏—Å–∞–Ω–Ω–æ–π –∑–∞–ø–∏—Å—å—é
- **Hash**: –ö—Ä–∏–ø—Ç–æ–≥—Ä–∞—Ñ–∏—á–µ—Å–∫–æ–µ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–µ —Ü–µ–ª–æ—Å—Ç–Ω–æ—Å—Ç–∏

---

## üíª –ü—Ä–∏–º–µ—Ä—ã –ö–æ–¥–∞

### –î–æ–±–∞–≤–ª–µ–Ω–∏–µ Validation Metadata

```typescript
// Zod schema –¥–ª—è –ª—é–±–æ–π validated table
const ValidatedEntitySchema = z.object({
  // ... existing fields ...
  
  // Validation lifecycle
  validation_status: z.enum(['validated', 'pending', 'expired']),
  validation_protocol_id: z.string().uuid().optional(),
  last_validated_at: z.date().optional(),
  next_review_date: z.date().optional(),
  
  // Change control
  change_control_id: z.string().uuid().optional(),
  
  // Retention
  retention_policy_id: z.string().uuid().optional(),
});
```

### E-Signature —Å FDA Compliance

```typescript
const EnhancedSignatureSchema = z.object({
  signature_id: z.string().uuid(),
  user_id: z.string().uuid(),
  signed_at: z.date(),
  
  // FDA ¬ß 11.50 - Meaning
  meaning: z.enum([
    'authorship',
    'review', 
    'approval',
    'verification',
    'witnessing',
    'release'
  ]),
  
  // FDA ¬ß 11.70 - Linking
  signed_entity_type: z.string(), // 'batch', 'deviation', 'change_request'
  signed_entity_id: z.string().uuid(),
  linked_record_hash: z.string().length(64), // SHA-256
  
  // Critical operations witness
  witness_signature_id: z.string().uuid().optional(),
  witness_required: z.boolean(),
});
```

---

## üìû –ö–æ–º—É –ó–∞–¥–∞–≤–∞—Ç—å –í–æ–ø—Ä–æ—Å—ã

### –ü–æ Compliance

- **FDA 21 CFR Part 11**: –°–º. `/docs/compliance/FDA_21CFR_Part11.md`
- **EU GMP Annex 11**: –°–º. `/docs/compliance/EU_GMP_Annex11.md`
- **ALCOA+**: –°–º. `/docs/compliance/ALCOA+.md`

### –ü–æ –¢–µ—Ö–Ω–∏—á–µ—Å–∫–∏–º –í–æ–ø—Ä–æ—Å–∞–º

- **DS.md**: `/docs/validation/DS.md` (v1.0, —Ç—Ä–µ–±—É–µ—Ç –æ–±–Ω–æ–≤–ª–µ–Ω–∏—è)
- **Data Dictionary**: `/docs/data_dictionary/README.md`
- **Contract Specs**: `/docs/CONTRACT_SPECIFICATIONS.md`

### –ü–æ –ü—Ä–æ—Ü–µ—Å—Å—É

- **Action Plan**: –°–º. `DS_UPDATE_ACTION_PLAN.md`
- **Compliance Matrix**: –°–º. `DS_COMPLIANCE_MATRIX.md`

---

## ‚ö° Quick Commands

### –ù–∞–π—Ç–∏ –≤—Å–µ —Å—Å—ã–ª–∫–∏ –Ω–∞ DS —Å—Ç—Ä—É–∫—Ç—É—Ä—ã

```bash
grep -r "DS-[A-Z]\{2,\}-[0-9]\{3\}" docs/
```

### –ü—Ä–æ–≤–µ—Ä–∏—Ç—å compliance coverage

```bash
# –°–º. DS_COMPLIANCE_MATRIX.md –¥–ª—è —Ç–µ–∫—É—â–µ–≥–æ —Å—Ç–∞—Ç—É—Å–∞
cat docs/reports/DS_COMPLIANCE_MATRIX.md | grep "Coverage:"
```

### –°–æ–∑–¥–∞—Ç—å –Ω–æ–≤—É—é DS —Å—Ç—Ä—É–∫—Ç—É—Ä—É

1. –î–æ–±–∞–≤–∏—Ç—å –≤ `/docs/validation/DS.md`
2. –û–±–Ω–æ–≤–∏—Ç—å `/docs/reports/DS_COMPLIANCE_MATRIX.md`
3. –°–æ–∑–¥–∞—Ç—å migration script
4. –û–±–Ω–æ–≤–∏—Ç—å Zod schemas –≤ `/docs/CONTRACT_SPECIFICATIONS.md`

---

## üéØ Success Criteria

### DS.md v2.0 –≥–æ—Ç–æ–≤ –∫–æ–≥–¥–∞

- ‚úÖ –í—Å–µ Phase 1 –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏–µ —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –¥–æ–±–∞–≤–ª–µ–Ω—ã
- ‚úÖ –í—Å–µ —Å—É—â–µ—Å—Ç–≤—É—é—â–∏–µ —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –¥–æ–ø–æ–ª–Ω–µ–Ω—ã compliance –ø–æ–ª—è–º–∏
- ‚úÖ ALCOA+ mapping –¥–ª—è –∫–∞–∂–¥–æ–π —Ç–∞–±–ª–∏—Ü—ã
- ‚úÖ Traceability matrix –æ–±–Ω–æ–≤–ª–µ–Ω–∞
- ‚úÖ QA Review completed
- ‚úÖ Approval signatures captured

### System –≥–æ—Ç–æ–≤–∞ –∫ Production –∫–æ–≥–¥–∞

- ‚úÖ FDA 21 CFR Part 11: 95%+ coverage
- ‚úÖ EU GMP Annex 11: 95%+ coverage
- ‚úÖ ALCOA+: 90%+ coverage
- ‚úÖ –í—Å–µ –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏–µ gaps –∑–∞–∫—Ä—ã—Ç—ã
- ‚úÖ Mock audit passed
- ‚úÖ External compliance consultant sign-off

---

## üìä Progress Tracking

### Current Status

```text
Week: 0 (Baseline)
Phase: Planning & Analysis
Completion: 0%

Critical Issues: 40 open
High Priority: 67 open
Medium Priority: 88 open
```

### Target Milestones

```text
Week 2: Phase 1 complete (Critical structures added)
Week 4: Phase 2 complete (High-priority enhancements)
Week 6: Phase 3 complete (Restructuring & final compliance)
```

---

## üöÄ Get Started

1. **Read** [DATA_DICTIONARY_SUMMARY.md](./DATA_DICTIONARY_SUMMARY.md)
2. **Review** [DS_UPDATE_ACTION_PLAN.md](./DS_UPDATE_ACTION_PLAN.md)
3. **Check** [DS_COMPLIANCE_MATRIX.md](./DS_COMPLIANCE_MATRIX.md)
4. **Start** Phase 1 implementation
5. **Track** Progress daily

**Next Meeting**: Team review of Action Plan  
**Deadline**: Phase 1 completion by Week 2  
**Owner**: Development Team Lead + QA Manager

---

**Created**: 2025-10-16  
**Status**: Ready for team review  
**Priority**: üî¥ CRITICAL - P0 Blocker
